Company Active LTD

Company profile

GP Strategies Limited

UK company 08003789, incorporated on 23 March 2012.

UK Apprenticeships Training Providers - GP Strategies Ltd

GP Strategies Training is a nationwide apprenticeship training provider & apprentice recruitment specialist. Explore our apprenticeships to aid your future.

Company number
08003789
Incorporated
23 Mar 2012
Companies House status
Active

Company identity

Founded / incorporated
23 March 2012

Company number 08003789

Verify at Companies House
Legal name
GP STRATEGIES LIMITED
Company type
LTD
Region
London
Registered address
Unknown
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

7 events
25 Sep
2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzU0NzY1NDk5OWFkaXF6a2N4

Published 25 Sep 2026 18:08

25 Sep
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzU0NzY1NDk3N2FkaXF6a2N4

Published 25 Sep 2026 18:07

25 Sep
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzU0NzY1NDkyNWFkaXF6a2N4

Published 25 Sep 2026 18:05

25 Sep
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzU0NzY1NDg2MGFkaXF6a2N4

Published 25 Sep 2026 18:03

25 Sep
2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzU0NzY1NDgxNGFkaXF6a2N4

Published 25 Sep 2026 18:01

25 Sep
2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzU0NzY1NDgwNmFkaXF6a2N4

Published 25 Sep 2026 18:01

23 Mar
2012

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2012
Funded years
2012
Age at first award
0 years

Projects

2012 Collaborative R&D

EktoTherix: Initial clinical evaluation of a regenerative tissue scaffold for repair of surgical excision wounds

1 Feb 2012 to 31 Oct 2016

Awarded
£43,159
Total cost £71,931

Neotherix (York UK) has developed the EktoTherix™ bioresorbable scaffold material that assists patient tissue repair and regeneration, with an initial target clinical application of non-melanoma skin cancers (NMSC) with further indications to follow. A patch of the material is used following excision of the basal or squamous carcinoma by the clinician, an...

Product types

Collaborative R&D